drugset / Trial / NCT01243788
The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD
Phase 4
Unknown
450 enrolled
Fudan University
Armed Police Medical college Affiliated Hospital · collabBeijing Chao Yang Hospital · collabGuangzhou First People's Hospital · collabHenan Provincial People's Hospital · collabLiaoning Cancer Hospital & Institute · collabPeking Union Medical College Hospital · collabPeking University Third Hospital · collabQingdao University · collabShanghai Zhongshan Hospital · collabThe First Affiliated Hospital of Anhui Medical University · collabThe First Affiliated Hospital of Guangzhou Medical University · collabThe First Affiliated Hospital with Nanjing Medical University · collabWest China Hospital · collabXinqiao Hospital of Chongqing · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine the efficacy and safety of Salmeterol/Fluticasone Propionate 50/500ug BID vs Ipratropium/Albuterol 36/206ug QID in Chinese patients with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD).
Timeline
- Start
- 2009-07
- Primary completion
- 2011-02
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone propionate | Other / unclassified | 500 ug | Inhaled |
| Comparator | Salmeterol | Other / unclassified | 50 ug | Inhaled |